Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients.
about
Current immunotherapeutic strategies in hepatocellular carcinoma: recent advances and future directions.Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.Myeloid-derived suppressor cells coming of age.Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma.
P2860
Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Neutrophil count is associated ...... tocellular carcinoma patients.
@ast
Neutrophil count is associated ...... tocellular carcinoma patients.
@en
type
label
Neutrophil count is associated ...... tocellular carcinoma patients.
@ast
Neutrophil count is associated ...... tocellular carcinoma patients.
@en
prefLabel
Neutrophil count is associated ...... tocellular carcinoma patients.
@ast
Neutrophil count is associated ...... tocellular carcinoma patients.
@en
P2093
P2860
P356
P1433
P1476
Neutrophil count is associated ...... tocellular carcinoma patients.
@en
P2093
Ai-Hua Lei
Qiang Xiao
Xiang-Yuan Wu
Yan-Fang Xing
Ying-Fen Hong
Zhi-Huan Lin
P2860
P304
24380-24388
P356
10.18632/ONCOTARGET.15456
P407
P577
2017-02-17T00:00:00Z